Skip to content

Comparing the Effect of Spinal Bupivacaine Versus Spinal Prilocaine on Maternal Blood Pressure in Cesarean Section

Comparison Between the Effect of Spinal Bupivacaine Versus Spinal Prilocaine on Maternal Blood Pressure in Cesarean Section

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06290583
Enrollment
120
Registered
2024-03-04
Start date
2024-04-21
Completion date
2025-01-01
Last updated
2025-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Anesthetics Causing Adverse Effects in Therapeutic Use

Brief summary

one of the most common complications associated with spinal anesthesia is hypotension, which can have adverse effects on both the mother and the fetus. The present study compare prilocaine versus bupivacaine in spinal anesthesia on hypotension and there effect on maternal outcomes.

Interventions

DRUGBupivacaine

Spinal anesthesia with standard dose of bupivacaine

Spinal anesthesia with 50 mg dose of Prilocaine.

Sponsors

South Valley University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Pregnant \>36 weeks singleton baby * American Society of Anesthesiologists (ASA) physical status 2 * Age : between 18 years old and 35 years old

Exclusion criteria

* Pregnant women with cardiac disease and history of psychiatric illness * Pregnant women who received spinal anesthesia and converted to general anesthesia * Women who have sensitivity to local anesthetics, * Women who have Eclampsia, abruption placenta or placenta previa * Women who have coagulopathy, thrombocytopenia with platelet count less than 80,000/cm3, myasthenia

Design outcomes

Primary

MeasureTime frameDescription
Maternal arterial blood pressureat base line before induction and every 3 minute during the first 15 min after spinal then every 5 mins until the end of surgery and every 1 hour postoperatively for 6 hoursNoninvasive blood pressure will be measured at selected time frame.. Hypotension will be defined as a decrease of systolic blood pressure of at least 20% from baseline. Upon its occurrence, and/or appearance of nausea and dizziness, treatment will be immediately with ephedrine 5mg/ dose

Secondary

MeasureTime frameDescription
Evaluation of duration of motor blockwill be assessed before skin incision and every 15 min intervals until the end of surgery and then at 30-min intervals until its complete regressionthe time to motor block regression (duration of motor block), defined as the time between complete block (score 1) after induction of prilocaine or bupivacaine and no motor block (score 6) on the Modified Bromage scale (1, complete motor block; 2, almost complete motor block, ability to move the feet only; 3, ability to move the knees; 4, ability to raise the leg but unable to keep it raised; 5, ability to keep the leg raised for 10 s; 6, no weakness).
Total dose of ephedrineFrom beginning of administration of spinal anesthesia until complete regression of motor blockadeWhen hypotension occurred postspinal ephedrine 5mg per dose will be given to restore blood pressure to 90% of its baseline value.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026